Acumen

AAIC 2023 – Acumen’s new amyloid approach impresses
EP Vantage
Wed, 07/19/23 - 10:15 am
AAIC
Acumen
Alzheimer's disease
ACU193
Acumen rides aducanumab, amyloid and Alzheimer's waves on its IPO voyage
Fierce Biotech
Thu, 06/10/21 - 11:04 am
Acumen
IPOs
Aduhelm
Biogen
Merck & Co. Axes Alzheimer Deal with Acumen
Genetic Engineering News
Wed, 12/21/11 - 01:11 pm
Merck
Alzheimer's disease
Acumen
anti-ADDL